Video: Andreas Chrysostomou discusses the new AICPA Accounting and Valuation Guide: Assets Acquired to be Used in Research and Development

Duff & Phelps Managing Director and Healthcare and Life Sciences industry leader Andreas Chrysostomou discusses some of the highlights of the new AICPA Accounting and Valuation Guide on IPR&D. Discussion topics include the risks of not valuing IPR&D properly, the now permissible relief from royalty method, treatment of consideration and milestone payments, and acceptable approaches for selecting the appropriate discount rate. 

Watch the video

2014-03-07T00:00:00.0000000 0001-01-01T00:00:00.0000000 /about-us/news/2014/video-andreas-chrysostomou-discusses-the-new-aicpa-accounting-and-valuation-guide-assets-acquired-to-be-used-in-research-and-development news {B062D54C-1425-4A04-8F9F-95EA14068E6D} {E010DCD9-B7BA-4B98-9F3C-A51506B5C1D8}

Related Services

Duff & Phelps Valuation Advisory Services

Valuation Advisory

Valuation and consulting for financial reporting, federal, state and local tax, investment and risk management purposes.

Valuation Advisory
Duff & Phelps Valuation Advisory Services

Valuation Advisory

Valuation Services

Objective valuations for financial reporting, tax and management planning purposes.

Valuation Services

Case Studies

Insights

Events